Catalent

+$2.81 (+2.41%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Catalent and other ETFs, options, and stocks.

About CTLT

Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services.

CEO

John R. Chiminski

Employees

13,900

Headquarters

Somerset, New Jersey

Founded

1933

CTLT Key Statistics

Market Cap

20.33B

Price-Earnings Ratio

39.17

Dividend Yield

—

Average Volume

665.48K

High Today

$120.17

Low Today

$116.99

Open Price

$117.00

Volume

746.92K

52 Week High

$127.68

52 Week Low

$79.65

CTLT News

Simply Wall StJul 26

Here's Why We Think Catalent Is Well Worth Watching

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story stocks' without revenue, let alone profit.

Analyst Ratings

93%

of 14 ratings

Buy

92.9%

Hold

7.1%

Sell

CTLT Earnings

$0.00

$0.30

$0.60

$0.90

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected Aug 30, Pre-Market